Cangene (FRA:YGE) Days Sales Outstanding : 87.85 (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Days Sales Outstanding?

Cangene's average Accounts Receivable for the three months ended in Oct. 2013 was €17.37 Mil. Cangene's Revenue for the three months ended in Oct. 2013 was €18.04 Mil. Hence, Cangene's Days Sales Outstanding for the three months ended in Oct. 2013 was 87.85.

The historical rank and industry rank for Cangene's Days Sales Outstanding or its related term are showing as below:

FRA:YGE's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 73.24
* Ranked among companies with meaningful Days Sales Outstanding only.

Cangene's Days Sales Outstanding increased from Oct. 2012 (69.66) to Oct. 2013 (87.85).

Cangene Days Sales Outstanding Historical Data

The historical data trend for Cangene's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Days Sales Outstanding Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Days Sales Outstanding

Get a 7-Day Free Trial

53.97

57.52

49.27

65.13

64.50

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Days Sales Outstanding	Get a 7-Day Free Trial															69.66	99.83	69.86	110.48	87.85

Competitive Comparison of Cangene's Days Sales Outstanding

For the Biotechnology subindustry, Cangene's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cangene's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cangene's Days Sales Outstanding falls into.

Cangene Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cangene's Days Sales Outstanding for the fiscal year that ended in Jul. 2013 is calculated as

	Days Sales Outstanding (A: Jul. 2013 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jul. 2012 )	+	Accounts Receivable (A: Jul. 2013 ))	/	count )	/	Revenue (A: Jul. 2013 )	*	Days in Period
=	( (18.177	+	16.201)	/	2 )	/	97.269	*	365
=	17.189					/	97.269	*	365
=	64.50

Cangene's Days Sales Outstanding for the quarter that ended in Oct. 2013 is calculated as:

	Days Sales Outstanding (Q: Oct. 2013 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jul. 2013 )	+	Accounts Receivable (A: Oct. 2013 ))	/	count )	/	Revenue (A: Oct. 2013 )	*	Days in Period
=	( (16.201	+	18.541)	/	2 )	/	18.043	*	365 / 4
=	17.371					/	18.043	*	365 / 4
=	87.85

Cangene (FRA:YGE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cangene Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cangene's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines